Redmile Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.2M | Sell |
|
|||||
|
2025
Q1 | $133M | Sell |
|
|||||
|
2024
Q4 | $118M | Sell |
|
|||||
|
2024
Q3 | $147M | Sell |
|
|||||
|
2024
Q2 | $188M | Sell |
|
|||||
|
2024
Q1 | $268M | Sell |
|
|||||
|
2023
Q4 | $215M | Sell |
|
|||||
|
2023
Q3 | $232M | Sell |
|
|||||
|
2023
Q2 | $301M | Buy |
|
|||||
|
2023
Q1 | $153M | Buy |
|
|||||
|
2022
Q4 | $150M | Sell |
|
|||||
|
2022
Q3 | $132M | Buy |
|
|||||
|
2022
Q2 | $125M | Buy |
|
|||||
|
2022
Q1 | $121M | Sell |
|
|||||
|
2021
Q4 | $127M | Sell |
|
|||||
|
2021
Q3 | $104M | Sell |
|
|||||
|
2021
Q2 | $141M | Buy |
|
|||||
|
2021
Q1 | $159M | Buy |
|
|||||
|
2020
Q4 | $101M | Buy |
|
|||||
|
2020
Q3 | $64.7M | Buy |
|
|||||
|
2020
Q2 | $58.4M | Buy |
|
|||||
|
2020
Q1 | $45.5M | Sell |
|
|||||
|
2019
Q4 | $60.4M | Buy |
|
|||||
|
2019
Q3 | $37.4M | Sell |
|
|||||
|
2019
Q2 | $43.5M | Buy |
|
|||||
|
2019
Q1 | $10.7M | Sell |
|
|||||
|
2018
Q4 | $6.75M | Buy |
|